Company / Revenue
Thermo Fisher Scientific Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$44.6B
FY2025
5-year range
$25.5B / $44.6B
FY2021-FY2025
Trend
+3.9%
vs FY2024
Sector context
#11 of 156
Health Care
What the data says
Among 156 Health Care companies, Thermo Fisher Scientific is in the top 7% for revenue. Revenue has increased for 4 consecutive years, from $25.5B in FY2021 to $44.6B in FY2025.
Based on SEC 10-K filings.
$44.6B in FY2025 with a 5-year CAGR of +6.7%. Top quartile in the Health Care sector.
Improved from $39.2B to $44.6B over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +11.4%
- 5-Year CAGR
- +6.7%
- 10-Year CAGR
- -
Sector benchmark
Top 7% in Health CareTop 7% of 156This company $44.6B Sector average $19.0B
▼
+134.5% above sector average
Key checks
Key Insights
- Thermo Fisher Scientific's revenue has grown for 4 consecutive years.
- 5-year CAGR of +6.7%, indicating consistent growth.
- In FY2025, revenue increased 3.9% year-over-year.
- Ranks #11 out of 156 companies in the Health Care sector.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $44.6B | +3.9% |
| FY2024 | $42.9B | +9.4% |
| FY2023 | $39.2B | +21.7% |
| FY2022 | $32.2B | +26.1% |
| FY2021 | $25.5B | -20.7% |
| FY2020 | $32.2B | +26.1% |
| FY2019 | $25.5B | +4.9% |
| FY2018 | $24.4B | +411.2% |
| FY2017 | $4.8B | -73.9% |
| FY2016 | $18.3B | +7.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026